VEGFA and neoplasm: Namely, BPC 157 may increase and decrease and thereby control, VEGF expression during wound healing— for example, healing of a detached or transected tendon or muscle (Brcic et al., 2009)—and BPC 157 may have a prominent angiogenic effect during healing (Brcic et al., 2009; Hsieh et al., 2017; Huang et al., 2015; Sikiric et al., 1999) while counteracting the tumor‐promoting the effect of VEGF (Radeljak, Seiwerth, & Sikiric, 2004).